Pagina 4 - I migliori medici di Radioterapia - TOP-95medici

Il medico è un radioterapista altamente esperto, specializzato in tecniche avanzate di terapia radiante per il trattamento del cancro. Con oltre 15 anni di pratica, ha contribuito in modo significativo al campo attraverso la ricerca e le sperimentazioni cliniche, con l'obiettivo di migliorare i risultati dei pazienti. Il medico è stato riconosciuto per la sua esperienza in radiochirurgia stereotassica e terapia radiante modulata in intensità, fornendo cure all'avanguardia ai pazienti. Ha pubblicato numerosi articoli sottoposti a revisione paritaria ed è un frequente relatore in conferenze internazionali di oncologia.<\/p>

Dr. Iris Kventsel, MD, is a pediatric hemato-oncologist and bone marrow transplant (BMT) specialist at Sheba Medical Center. She is an attending physician in the Pediatric Hemato-Oncology and BMT Division at the Edmond and Lily Safra Children’s Hospital. Her clinical focus is pediatric sarcomas, including Ewing sarcoma, osteosarcoma, and rhabdomyosarcoma.

She provides multidisciplinary care, including transplant and cellular therapies. She also uses current chemotherapy protocols and targeted therapies for complex childhood cancers.

Her research focuses on genetic cancer predisposition, including Li-Fraumeni syndrome, and cancer susceptibility genes. She has published in pediatric oncology, stem cell biology, and surgical oncology (HIPEC). She is on the academic staff at Tel Aviv University. Education: MD, Technion; Pediatrics residency, Assaf HaRofeh; Pediatric Hemato-Oncology fellowship, Sheba.

Dr. Eytan Aharon Ben‑Ami, MD, is a Senior Physician in the Sarcoma and Bone Oncology Service at Sheba Medical Center. He heads the Oncology Division and the Early-Phase Clinical Trials Unit. He founded the Sheba Clinical Research Organization. He is an academic affiliate at Tel Aviv University.

He specializes in sarcomas and primary bone tumors, including soft tissue sarcoma, liposarcoma, leiomyosarcoma, and osteosarcoma. He leads Phase I trials in targeted therapy and immunotherapy. He designs personalized treatment plans for rare cancers. He also develops patient-centered programs, including pilots in advanced immunotherapy delivery.

He completed a fellowship in Sarcoma and Bone Oncology at the Dana-Farber Cancer Institute/Harvard Cancer Center. He has authored more than 40 publications on early detection, molecular and viral mechanisms, and new cancer therapies.

Dr. Yaacov Lawrence, MA, MBBS, MRCP, is Chair of Radiation Oncology at Sheba Medical Center. He has nearly 30 years of experience in precision radiation oncology and neuro-oncology.

He is an expert in advanced radiation therapy and radiosurgery. He performs stereotactic radiosurgery for brain tumors. He leads Sheba’s GI Cancer Program in gastrointestinal oncology. He also provides precision care for lung and prostate cancers. He pioneered celiac plexus radiosurgery for severe pain from pancreatic cancer.

Training and credentials: MA and MBBS (Cambridge and UCLH); MRCP (RCP); Radiation Oncology fellowship (Thomas Jefferson University). Honors include the ASCO Young Investigator Award and Fellow of ASTRO (FASTRO). He has authored over 280 publications. He is Director of the Center for Translational Radiation Oncology and an Associate Professor at Tel Aviv University.

Il medico è un oncologo altamente esperto con un focus su trattamenti innovativi per il cancro e cure personalizzate per i pazienti. Con oltre 15 anni di esperienza nel campo, il medico ha contribuito significativamente ai progressi nella chemioterapia e nell'immunoterapia. Il medico è certificato dal consiglio e ha pubblicato numerosi articoli di ricerca su riviste mediche prestigiose. Il medico è anche attivamente coinvolto in studi clinici ed è stato relatore principale in diverse conferenze internazionali di oncologia.<\/p>

Il medico è un oncologo altamente esperto con un focus su metodologie innovative di trattamento del cancro. Con oltre 15 anni di pratica clinica, il medico ha trattato con successo una vasta gamma di malignità utilizzando terapie all'avanguardia e approcci di medicina personalizzata. Il medico è certificato dal consiglio e ha contribuito a numerose pubblicazioni sottoposte a revisione paritaria in riviste di oncologia. Inoltre, il medico è stato coinvolto in diversi progetti di ricerca rivoluzionari mirati a migliorare i risultati dei pazienti e ha presentato i risultati in conferenze internazionali.<\/p>

Dr. Hilmi Apak is a respected pediatric hematology-oncology specialist with more than 21 years of experience. He is trained in pediatric oncology. Dr. Apak has led advanced treatments, including bone marrow transplantation, leukemia chemotherapy, and CAR T-cell therapy.

He has published 75 international medical articles, showing his strong contribution to pediatric oncology research. Dr. Apak has worked as assistant editor for the Turkish Pediatrics Archives Periodical. He has also held important academic and leadership positions, such as Head of Pediatric Hematology-Oncology at Istanbul University-Cerrahpaşa.

Il medico è un oncologo radioterapista altamente esperto con 19 anni in radio-oncologia, specializzato in radioterapia 4D e IMRT per l'irradiazione tumorale ad alta precisione. Il medico si è laureato presso la Facoltà di Medicina dell'Università di Istanbul e ha proseguito gli studi in radiochirurgia presso l'Università della Carolina del Nord.<\/p>

Dal 2012, il medico pratica presso l'Istituto del Cancro di Istanbul e attualmente lavora presso il Liv Hospital, la più grande rete sanitaria della Turchia. Il medico è esperto in diagnostica per immagini, inclusi MRI, CT e PET-CT.<\/p>

Il medico ha contribuito a 25 pubblicazioni scientifiche internazionali e 11 nazionali e ha partecipato a 16 conferenze internazionali. Le affiliazioni includono TROD, ASTRO ed ESTRO.<\/p>

Il medico è un oncologo radioterapista esperto con 36 anni nel campo, specializzato nelle tecniche VMAT e IMRT. Membro attivo di molteplici società mediche, il medico ha iniziato gli studi medici presso le Università di Heidelberg e Kiel nel 1972 e ha completato la formazione in Oncologia Radioterapica e Radiologia Diagnostica presso l'Università di Essen nel 1980.<\/p>

Il medico è un membro fondatore del Gruppo Interdisciplinare Testa e Collo della Società Tedesca di Cancro e ha contribuito a numerosi articoli ben documentati in riviste nazionali e internazionali sottoposte a revisione paritaria.<\/p>

Sema Yılmaz was born on July 30, 1965. She received her undergraduate degree from Istanbul University Cerrahpaşa Medical Faculty and completed her medical residency training at the Department of Pediatrics at Zeynep Kamil Women's and Children's Health and Diseases Hospital. She also completed her medical subspecialty training in Pediatric Hematology/Oncology at Cukurova University. Her medical residency thesis was titled "The Relationship Between Morning First Urine Density and Nocturnal Enuresis in Children Aged 3-6 Years", and her medical subspecialty thesis was titled "Comparison of Sphingosine 1-phosphate Receptor 4 Gene Expression in Healthy Children and Neuroblastoma Patients". She started her medical career as a general practitioner. After working as a general practitioner for 4 years, she worked as a doctor researcher at Zeynep Kamil Women's and Children's Health and Diseases Training and Research Hospital for 5 years. She then served as a specialist doctor, assistant professor, and associate professor at various institutions. She worked at Houston MD Anderson, North Carolina-UNC, Boston-Harvard University in the USA. Additionally, she conducted research on cell therapies. She received the title of professor in Pediatric Hematology/Oncology at Usak Medical Faculty. She is a member of the Turkish Pediatric Oncology Group, European Association for Cancer Research (EACR), Turkish Medical Association, Turkish National Pediatrics Association, Turkish Pediatrics Association, Pediatrics Specialty Academy Association (PUADER), Turkish Immunology Association, Turkish Hematology Association, and Molecular Oncology Association (MOKAD). She currently serves her patients at Koru Hospital. Her medical interests include:

Cell therapies in childhood cancers

Cancer immunology

Investigation of genetic pathways responsible for cancer and metastasis

Pulmonary microbiota

BAL transplantation

Oncologist, dermatologist

Il medico è un oncologo chirurgo esperto con 20 anni di pratica, specializzato in oncologia clinica e radioterapia. Riconosciuto come uno dei principali specialisti in sarcomi in Ucraina, il medico ha scritto tre brevetti medici e contribuito a 50 articoli sul trattamento del cancro. Attualmente, il medico è il Direttore Medico della Clinica Spizhenko e del Centro di Oncoconsulenza. Il medico ha ricoperto posizioni significative in varie istituzioni mediche, incluso il Centro Ucraino di Tomoterapia. Il medico è membro di diverse società oncologiche prestigiose, tra cui la Società Europea di Oncologia Medica e la Società Americana di Oncologia Clinica.<\/p>

Il medico è un oncologo certificato con oltre 15 anni di esperienza nel campo dell'oncologia medica. Specializzandosi nel trattamento dei tumori al seno e ai polmoni, il medico ha contribuito a numerosi studi clinici mirati allo sviluppo di terapie innovative contro il cancro. Il medico ha pubblicato oltre 50 articoli sottoposti a revisione paritaria su prestigiose riviste mediche, avanzando nella comprensione dei protocolli di trattamento del cancro. Inoltre, il medico è membro di diverse società oncologiche leader ed è stato relatore principale a conferenze internazionali di oncologia.<\/p>

Academic Education:

• Bachelor of Medicine and Surgery. University of Barcelona.
• Doctor in medicine. University of Barcelona. Extraordinary prize for doctoral thesis.
• Training in translational research thanks to a post-doctoral stay at Memorial Sloan-Kettering Cancer Center (New York, USA).

Professional Experience:

• Medical Oncologist specialized in urological cancer. Her areas of expertise are prostate cancer, kidney, bladder and urinary tract cancer, and testicular cancer.
• She currently works as a Senior Consultant in the Medical Oncology Service of the Hospital Clínic de Barcelona, ​​where she is responsible for urological cancer. 
• At HM Delfos, from Medical Oncology, she is responsible for the care of patients with urological cancer, from a multidisciplinary approach in coordination with the different specialists (urology, radiotherapy, pathology) through joint work and the Tumor Committee. She is also responsible for the introduction of new therapies and the development of clinical trial projects in this area.

Scientific and Teaching Activity:

• Associate Professor of the Faculty of Medicine of the Clinical Hospital. University of Barcelona. 
• Teaching in the subject of Medical Oncology, of the 5th year of the Degree in Medicine and Surgery at the University of Barcelona. She has been the director of several Final Degree projects for medical students in ​​urological cancer.
• Teacher and Director of the subject "Prostate Cancer" of the Master of Biomedicine. University of Barcelona.
• Teacher and Director of the subject "Comprehensive management of the uro-oncological patient", of the Master of Uro-Oncology of Advanced Medical Competences. University of Barcelona. 
• Direction of several doctoral theses on prostate cancer.
• Extensive experience in the training of Residents in Medical Oncology at the Clinical Hospital de Barcelona.
• Extensive teaching experience in scientific courses and symposiums.
• Internship tutor for students of the Master in Art Therapy at Escuela Metáfora. Art therapy in cancer patients at Hospital Clinic.
• Coordinator of Mindfulness training workshops in Oncology.
• Clinical research:   Extensive experience as principal investigator of multiple clinical trials, phase I, II and III, of new therapies in urological cancer.
• Translational research: Researcher at the August Pi i Sunyer Biomedical Research Institute (IDIBAPS). Leader of the Prostate Cancer working group, within the Translational Genomics Laboratory and Targeted Therapy in Solid Tumors. Her fundamental line of research is based on the investigation of resistance mechanisms to prostate cancer treatments and the study of biomarkers that allow progress towards personalized medicine in this disease.
• She has published more than 140 scientific articles in international journals.

Areas of Professional Interest:

• Her interest as a professional is to provide the best care for patients with urological cancer from all areas: the best care on an individual basis and offer them the best available treatment or the possibility of having access to new treatments within clinical trials. 
• In addition, she has a great interest in promoting comprehensive care for patients and their families.

Associate Professor Dr. Emrah Eraslan graduated from Ankara University Faculty of Medicine in 2005. From 2006 to 2011, he worked as a research assistant in the Department of Internal Medicine at Ankara University Faculty of Medicine and became an internal medicine specialist in 2011. Between 2011 and 2013, he worked as an internal medicine specialist and chief physician at Dr. Nafiz Körez Sincan State Hospital and Palu District State Hospital. From 2013 to 2016, he received medical oncology training at Dr. Abdurrahman Yurtaslan Ankara Oncology Education and Research Hospital and worked there until 2021. In 2023, he became an associate professor and contributed to his field with his publications throughout his career. He currently serves his patients at Koru Ankara Hospital. His medical interests include:

Breast Cancer

Prostate Cancer

Lung Cancer

Colorectal Cancer

Stomach Cancer

Ovarian Cancer

Il medico è un oncologo e radiologo esperto, specializzato in oncologia radioterapica. Con un'esperienza vasta nel campo, il medico ha contribuito significativamente ai progressi nei protocolli di trattamento del cancro e nella cura dei pazienti. Il medico è noto per l'implementazione di tecniche radiologiche all'avanguardia per migliorare i risultati dei pazienti ed è stato determinante nella conduzione di studi clinici che si concentrano su terapie innovative contro il cancro.<\/p>

Come capo del Dipartimento di Oncologia Radioterapica presso Fortis, il medico supervisiona un team dedicato a fornire cure oncologiche complete, garantendo i più alti standard di trattamento ed eccellenza nella ricerca.<\/p>